Inovio Pharmaceuticals, Inc. (INO): Total Liabilities
$50.21M
As of 2025-12-31
$45.02M
As of 2026-06-30
-26.4%
3-year compound annual growth
-8.6%
5-year compound annual growth
+2.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $50.21M | +12.4% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $44.69M | -16.6% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $53.60M | -57.5% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $126.17M | +31.1% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $96.27M | +22.4% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $78.63M | -43.2% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $138.55M | +214.3% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $44.08M | -1.5% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $44.75M | -11.1% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $50.33M | +32.8% | 2018-03-14, Balance as of period end |
| 2015-12-31 | $37.91M | +87.2% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $20.25M | -42.8% | 2016-03-14, Balance as of period end |
| 2013-12-31 | $35.38M | +244.2% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $10.28M | -22.4% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $13.24M | +47.7% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $8.97M | n/a | 2012-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $21.76M | -41.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $7.06M | +21.1% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $55.04M | +248.4% |
Compare INO, CNTB, SILO, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗